-

One Thousand New Vaccine Appointments Available This Week in Orem via Nomi Health

Appointments Also Available at Additional Nomi-Operated Larry H. Miller Megaplex Sites via GetMyShot.Utah.Gov

OREM, Utah--(BUSINESS WIRE)--Together with the Utah Department of Health, Nomi Health, the direct healthcare company coordinating COVID-19 testing and vaccination efforts across the country, has new appointments available starting Tuesday, March 16 for all eligible residents who qualify for the Moderna vaccine. The site is prepared to vaccinate 1,000 Utahns this week.

The registration process is simple, and available in both English and Spanish at https://getmyshot.utah.gov/. For any questions, the vaccine program helpline is available at (801) 704-5911, where support is accessible in both English and Spanish.

Orem Vaccination location and hours of operation:

  • Nomi’s Orem Facility, 1350 Sandhill Road, Orem
  • Operating Monday - Saturday, 8 a.m. - 6 p.m.

Nomi currently operates five additional vaccine sites in Larry H. Miller Megaplex theaters across Utah, Davis and Salt Lake counties, also available via https://getmyshot.utah.gov/ .

Eligible groups who can get the COVID-19 vaccine now include all Utahns 50+ years of age and older and people 16 years of age or older with medical conditions listed here. Additional eligible groups include healthcare workers who have contact with patients, long-term care facility staff and residents, first responders such as EMS personnel, law enforcement officers, dispatchers, and corrections officers, and K-12 school teachers and staff.

About Nomi Health

The way we pay and deliver healthcare in America today is fundamentally broken, burdened by layers of avoidable inefficiencies that drive up costs and create unnecessary delays in care. Founded in 2019, Nomi Health is a direct healthcare company with a simple yet bold mission: rewire how we pay for and deliver healthcare to create a more cost-effective -- and simply effective -- experience for employers, patients and providers alike. Our COVID-19 public health testing and vaccine programs are a perfect example of a more direct, digital-first health care model at work. Find out more at www.nomihealth.com.

Contacts

Jenny Olson
mPR, Inc. for Nomi Health
jenny@mpublicrelations.com
310-773-2568

Nomi Health


Release Versions

Contacts

Jenny Olson
mPR, Inc. for Nomi Health
jenny@mpublicrelations.com
310-773-2568

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom